Once again a nothing deal with very limited information keeping shareholders guessing on the profitability of the contract, for all we know they might only want to order 10,000 a year then that leaves us in the same position as we are now.
Price action is king and the market is clearly telling us something.
The high cash burn of this company will kill this company.
$$1bn dollar contract with $96 bn pharma, page-34
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)